1047.2000 2.95 (0.28%)
NSE Apr 09, 2026 10:12 AM
Volume: 11,608
 

1047.20
0.28%
Prabhudas Lilladhar
We believe the company is well poised to maintain consistent service quality as well as assure supply chain availability with its 1) leading manufacturing capabilities in key APIs, 2) strong relationship with global clients, 3) cost...
Number of FII/FPI investors increased from 92 to 98 in Dec 2025 qtr.
More from Alivus Life Sciences Ltd.
Recommended